Solid-phase molecularly imprinted pre-concentration and spectrophotometric determination of isoxicam in pharmaceuticals and human serum.
B Rezaei, S Mallakpour, N Majidi
文献索引:Talanta 78(2) , 418-23, (2009)
全文:HTML全文
摘要
A selective molecularly imprinted polymer (MIP) has been synthesized for isoxicam pre-concentration, followed by its spectrophotometric determination based on hydrogen bonding interactions between examined drug and alizarin yellow GG. This method is able to evaluate isoxicam in range of 1.0 x 10(-3) to 20.0 microg mL(-1), with a limit of determination of 1.0 ng mL(-1). The retention capacity and pre-concentration factor of prepared sorbent are 18.5 mg g(-1) and 200, respectively; and the prepared MIPs can be reused at least for five times. The MIP capability for isoxicam selection and extraction from the solution is higher than non-imprinted polymer (NIP). Under optimum conditions, this procedure can be successfully applied to assay trace amounts of isoxicam in pharmaceutical and biological samples.
相关化合物
相关文献:
1988-04-01
[Res. Commun. Chem. Pathol. Pharmacol. 60(1) , 19-25, (1988)]
1989-10-01
[Rev. Rhum. Mal. Osteoartic. 56(10) , 709-11, (1989)]
1988-01-01
[Curr. Med. Res. Opin. 11(1) , 28-33, (1988)]
1989-01-01
[Drug Metab. Dispos. 17(6) , 662-8, (1989)]
2009-04-01
[Bioanalysis 1(1) , 63-70, (2009)]